A Novel CaCu‐Metal–Organic‐Framework Based Multimodal Treatment Platform for Enhanced Synergistic Therapy of Hepatocellular Carcinoma
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202304000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Weijun Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Health Engineering, Jiangnan University, Wuxi, 214122, China. Hauptthemen laut MEDLINE: Doxorubicin, Metal-Organic Frameworks, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Metal ions have attracted a lot of interest in antitumor therapy due to their unique mechanism of action. However, multiple death mechanisms associate with metal ions to synergistic antitumors have few studies mainly due to the serious challenges in designing and building metal‐associated multimodal treatment platforms. Hence, a series of glutathione‐activatable CaCu‐based metal–organic‐frameworks loaded with doxorubicin and ovalbumin are successfully designed and synthesized with an “all in one” strategy, which is modified by galactosamine‐linked hyaluronic acid to prepare multimodal treatment platform (SCC/DOX@OVA‐HG) for targeted delivery and synergistic antitumor therapy. SCC/DOX@OVA‐HG can be rapidly degraded by the overexpressed glutathione and then releases the “cargoes” in the tumor microenvironment. The released Cu + efficiently catalyzes H 2 O 2 to produce highly toxic ROS for CDT, and the up‐regulation of calcium ion concentration in tumor cells induced by the released Ca 2+ enables calcium overload therapy, which synergically enhances the metal‐related death pattern. Meanwhile, OVA combined with Ca 2+ /Cu 2+ further activates macrophages into an M1‐like phenotype to accelerate tumor cell death through immunotherapy. Besides, the released DOX can also insert into the DNA double helix for chemotherapy. Consequently, the developed SCC/DOX@OVA‐HG reveals significantly improved antitumor efficacy through a multimodal synergistic therapy of chemotherapy, chemodynamic therapy, calcium overload, and immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences and Health Engineering, Jiangnan University, Wuxi, 214122, China.
- School of Chemical and Material Engineering, Jiangnan University, Wuxi, 214122, China.
- College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, 430072, China.
ORCID-Profile: Lipeng Qiu
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Chen, W., Yang, M., Wang, H., Song, J., Mei, C., Qiu, L., & Chen, J. (2024). A Novel CaCu‐Metal–Organic‐Framework Based Multimodal Treatment Platform for Enhanced Synergistic Therapy of Hepatocellular Carcinoma. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202304000
Vancouver
Chen W, Yang M, Wang H, Song J, Mei C, Qiu L, et al. A Novel CaCu‐Metal–Organic‐Framework Based Multimodal Treatment Platform for Enhanced Synergistic Therapy of Hepatocellular Carcinoma. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202304000
BibTeX
@article{Chen2024,
author = {Chen, Weijun and Yang, Meiyang and Wang, Huili and Song, Junling and Mei, Congjin and Qiu, Lipeng and Chen, Jinghua},
title = {A Novel CaCu‐Metal–Organic‐Framework Based Multimodal Treatment Platform for Enhanced Synergistic Therapy of Hepatocellular Carcinoma},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202304000}
}
EUVIMED